Clinical Trial: Duration of Protection: GSK DTaP Vaccines

Study Status: Completed
Recruit Status: Completed
Study Type: Observational




Official Title: Duration of Protection Following Five Doses of GlaxoSmithKline's (GSK's) DTaP Vaccines in School Age Children

Brief Summary: The purpose of this study is to assess duration of protection for GSK DTaP vaccines in preventing pertussis.